rs80356744
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_007375.4(TARDBP):c.*83T>C variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.0000131 in 1,523,352 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000095 ( 0 hom. )
Consequence
TARDBP
NM_007375.4 3_prime_UTR
NM_007375.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.54
Publications
1 publications found
Genes affected
TARDBP (HGNC:11571): (TAR DNA binding protein) HIV-1, the causative agent of acquired immunodeficiency syndrome (AIDS), contains an RNA genome that produces a chromosomally integrated DNA during the replicative cycle. Activation of HIV-1 gene expression by the transactivator Tat is dependent on an RNA regulatory element (TAR) located downstream of the transcription initiation site. The protein encoded by this gene is a transcriptional repressor that binds to chromosomally integrated TAR DNA and represses HIV-1 transcription. In addition, this protein regulates alternate splicing of the CFTR gene. A similar pseudogene is present on chromosome 20. [provided by RefSeq, Jul 2008]
MASP2 (HGNC:6902): (MBL associated serine protease 2) This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is proteolytically processed to generate A and B chains that heterodimerize to form the mature protease. This protease cleaves complement components C2 and C4 in order to generate C3 convertase in the lectin pathway of the complement system. The encoded protease also plays a role in the coagulation cascade through cleavage of prothrombin to form thrombin. Myocardial infarction and acute stroke patients exhibit reduced serum concentrations of the encoded protein. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
MASP2 Gene-Disease associations (from GenCC):
- immunodeficiency due to MASP-2 deficiencyInheritance: AR Classification: STRONG Submitted by: Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BS2
High AC in GnomAd4 at 7 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TARDBP | NM_007375.4 | c.*83T>C | 3_prime_UTR_variant | Exon 6 of 6 | ENST00000240185.8 | NP_031401.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TARDBP | ENST00000240185.8 | c.*83T>C | 3_prime_UTR_variant | Exon 6 of 6 | 1 | NM_007375.4 | ENSP00000240185.4 | |||
| TARDBP | ENST00000649624.1 | c.769-456T>C | intron_variant | Intron 5 of 5 | ENSP00000497327.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152208Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
7
AN:
152208
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000948 AC: 13AN: 1371144Hom.: 0 Cov.: 31 AF XY: 0.0000104 AC XY: 7AN XY: 673458 show subpopulations
GnomAD4 exome
AF:
AC:
13
AN:
1371144
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
673458
show subpopulations
African (AFR)
AF:
AC:
0
AN:
30508
American (AMR)
AF:
AC:
4
AN:
30196
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
21684
East Asian (EAS)
AF:
AC:
0
AN:
38522
South Asian (SAS)
AF:
AC:
0
AN:
70264
European-Finnish (FIN)
AF:
AC:
0
AN:
50204
Middle Eastern (MID)
AF:
AC:
0
AN:
3864
European-Non Finnish (NFE)
AF:
AC:
8
AN:
1069598
Other (OTH)
AF:
AC:
1
AN:
56304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
7
AN:
152208
Hom.:
Cov.:
33
AF XY:
AC XY:
5
AN XY:
74356
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41454
American (AMR)
AF:
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5204
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
7
AN:
68042
Other (OTH)
AF:
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: not provided
Submissions summary: Other:1
Revision: no classification provided
LINK: link
Submissions by phenotype
Amyotrophic lateral sclerosis type 10 Other:1
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.